Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein kinase C binding	UGT1A10 UGT1A8 UGT1A7 PKP2 UGT1A9 HDAC7	4.53e-07	66	88	6	GO:0005080
GeneOntologyMolecularFunction	retinoic acid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.65e-06	28	88	4	GO:0001972
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.66e-05	35	88	4	GO:0015020
GeneOntologyMolecularFunction	retinoid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.91e-05	48	88	4	GO:0005501
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	UGT1A10 UGT1A8 UGT1A7 UGT1A9 GALNT18 GALNT13	5.92e-05	153	88	6	GO:0008194
GeneOntologyMolecularFunction	isoprenoid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.41e-05	49	88	4	GO:0019840
GeneOntologyMolecularFunction	collagen binding involved in cell-matrix adhesion	ITGA10 ITGA1	1.90e-04	5	88	2	GO:0098639
GeneOntologyMolecularFunction	fatty acid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.45e-04	69	88	4	GO:0005504
GeneOntologyMolecularFunction	hexosyltransferase activity	UGT1A10 UGT1A8 UGT1A7 UGT1A9 GALNT18 GALNT13	3.42e-04	211	88	6	GO:0016758
GeneOntologyMolecularFunction	hyalurononglucosaminidase activity	SPAM1 CEMIP	6.78e-04	9	88	2	GO:0004415
GeneOntologyMolecularFunction	cell-matrix adhesion mediator activity	ITGA10 ITGA1	6.78e-04	9	88	2	GO:0098634
GeneOntologyMolecularFunction	monocarboxylic acid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.29e-03	107	88	4	GO:0033293
GeneOntologyMolecularFunction	glycosyltransferase activity	UGT1A10 UGT1A8 UGT1A7 UGT1A9 GALNT18 GALNT13	1.72e-03	288	88	6	GO:0016757
GeneOntologyBiologicalProcess	estrogen catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.40e-09	5	86	4	GO:0006711
GeneOntologyBiologicalProcess	phenylpropanoid catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.20e-09	6	86	4	GO:0046271
GeneOntologyBiologicalProcess	coumarin catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.20e-09	6	86	4	GO:0046226
GeneOntologyBiologicalProcess	flavone metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.20e-09	6	86	4	GO:0051552
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.80e-08	10	86	4	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.80e-08	10	86	4	GO:0009804
GeneOntologyBiologicalProcess	flavonoid metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.96e-07	13	86	4	GO:0009812
GeneOntologyBiologicalProcess	flavonoid glucuronidation	UGT1A8 UGT1A7 UGT1A9	6.96e-07	5	86	3	GO:0052696
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.60e-06	21	86	4	GO:0052695
GeneOntologyBiologicalProcess	hormone catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.60e-06	21	86	4	GO:0042447
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.93e-06	26	86	4	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.93e-06	26	86	4	GO:0006063
GeneOntologyBiologicalProcess	secondary metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	8.83e-06	67	86	5	GO:0019748
GeneOntologyBiologicalProcess	steroid catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.19e-05	34	86	4	GO:0006706
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT1A8 UGT1A7 UGT1A9	1.50e-05	12	86	3	GO:0052697
GeneOntologyBiologicalProcess	pigment metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	4.60e-05	94	86	5	GO:0042440
GeneOntologyBiologicalProcess	estrogen metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.55e-05	52	86	4	GO:0008210
GeneOntologyBiologicalProcess	maintenance of animal organ identity	PKP2 USH2A	1.70e-04	5	86	2	GO:0048496
Domain	UDPGT	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.25e-06	21	85	4	PF00201
Domain	UDPGT	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.25e-06	21	85	4	PS00375
Domain	UDP_glucos_trans	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.25e-06	21	85	4	IPR002213
Domain	ARM-type_fold	ATR RRP12 UBR4 INTS1 PKP2 PSMD1 TSC2 RALGAPA2	1.55e-04	339	85	8	IPR016024
Domain	fn3	EPHB2 COL12A1 KALRN ROS1 USH2A	8.66e-04	162	85	5	PF00041
Domain	Rap_GAP	TSC2 RALGAPA2	9.00e-04	10	85	2	PF02145
Domain	Rap_GAP_dom	TSC2 RALGAPA2	1.10e-03	11	85	2	IPR000331
Domain	RAPGAP	TSC2 RALGAPA2	1.10e-03	11	85	2	PS50085
Domain	APOBEC_N	APOBEC3B APOBEC4	1.31e-03	12	85	2	PF08210
Domain	APOBEC_N	APOBEC3B APOBEC4	1.31e-03	12	85	2	IPR013158
Domain	FN3	EPHB2 COL12A1 KALRN ROS1 USH2A	1.56e-03	185	85	5	SM00060
Domain	CYT_DCMP_DEAMINASES_2	APOBEC3B APOBEC4	2.07e-03	15	85	2	PS51747
Domain	VWA	COL12A1 ITGA10 ITGA1	2.12e-03	56	85	3	PF00092
Domain	FN3	EPHB2 COL12A1 KALRN ROS1 USH2A	2.15e-03	199	85	5	PS50853
Domain	Laminin_G	FAT2 COL12A1 USH2A	2.34e-03	58	85	3	IPR001791
Domain	FN3_dom	EPHB2 COL12A1 KALRN ROS1 USH2A	2.66e-03	209	85	5	IPR003961
Domain	CYT_DCMP_DEAMINASES_1	APOBEC3B APOBEC4	2.66e-03	17	85	2	PS00903
Domain	CMP_dCMP_Zn-bd	APOBEC3B APOBEC4	2.66e-03	17	85	2	IPR002125
Domain	Integrin_alpha-2	ITGA10 ITGA1	2.99e-03	18	85	2	IPR013649
Domain	Integrin_alpha2	ITGA10 ITGA1	2.99e-03	18	85	2	PF08441
Domain	Integrin_alpha	ITGA10 ITGA1	2.99e-03	18	85	2	IPR000413
Domain	INTEGRIN_ALPHA	ITGA10 ITGA1	2.99e-03	18	85	2	PS00242
Domain	Int_alpha_beta-p	ITGA10 ITGA1	3.33e-03	19	85	2	IPR013519
Domain	Int_alpha	ITGA10 ITGA1	3.33e-03	19	85	2	SM00191
Domain	-	ATR RRP12 PKP2 PSMD1 TSC2	3.44e-03	222	85	5	1.25.10.10
Domain	FG_GAP	ITGA10 ITGA1	4.46e-03	22	85	2	PS51470
Domain	FG-GAP	ITGA10 ITGA1	5.29e-03	24	85	2	PF01839
Domain	FG-GAP	ITGA10 ITGA1	5.29e-03	24	85	2	IPR013517
Domain	Integrin_dom	ITGA10 ITGA1	5.74e-03	25	85	2	IPR032695
Domain	Ricin_B_lectin	GALNT18 GALNT13	5.74e-03	25	85	2	PF00652
Pathway	WP_ESTROGEN_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.83e-06	22	65	4	MM15888
Pathway	REACTOME_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.08e-06	24	65	4	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.84e-06	25	65	4	M17787
Pathway	WP_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.84e-06	25	65	4	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.84e-06	25	65	4	M605
Pathway	WP_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.70e-06	26	65	4	M39404
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.76e-06	28	65	4	M19580
Pathway	REACTOME_PARACETAMOL_ADME	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.00e-05	39	65	4	MM15695
Pathway	WP_CODEINE_AND_MORPHINE_METABOLISM	UGT1A10 UGT1A8 UGT1A9	3.28e-05	14	65	3	M39328
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.67e-05	41	65	4	M7399
Pathway	REACTOME_ASPIRIN_ADME	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.32e-05	45	65	4	MM15694
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.74e-05	51	65	4	M17726
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.44e-05	52	65	4	M14171
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.18e-04	55	65	4	M14933
Pathway	KEGG_RETINOL_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.13e-04	64	65	4	M9488
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.00e-04	70	65	4	M16794
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-04	72	65	4	M9257
Pathway	REACTOME_MRNA_EDITING_C_TO_U_CONVERSION	APOBEC3B APOBEC4	4.33e-04	7	65	2	MM15412
Pathway	REACTOME_MRNA_EDITING_C_TO_U_CONVERSION	APOBEC3B APOBEC4	5.76e-04	8	65	2	M27683
Pathway	WP_METAPATHWAY_BIOTRANSFORMATION	UGT1A10 UGT1A8 UGT1A7 NDST4 UGT1A9	6.90e-04	153	65	5	MM15844
Pathway	REACTOME_CHL1_INTERACTIONS	ITGA10 ITGA1	7.38e-04	9	65	2	M27379
Pathway	REACTOME_MRNA_EDITING	APOBEC3B APOBEC4	7.38e-04	9	65	2	MM15445
Pathway	REACTOME_MRNA_EDITING	APOBEC3B APOBEC4	9.20e-04	10	65	2	M27709
Pathway	PID_TCPTP_PATHWAY	ATR ITGA1 PIAS1	9.45e-04	42	65	3	M91
Pathway	REACTOME_ASPIRIN_ADME	UGT1A8 UGT1A7 UGT1A9	1.08e-03	44	65	3	M45014
Pathway	WP_IRINOTECAN_PATHWAY	UGT1A10 UGT1A9	1.34e-03	12	65	2	M39611
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.49e-03	107	65	4	MM14595
Pathway	REACTOME_DRUG_ADME	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-03	109	65	4	M45012
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-03	109	65	4	M18788
Pubmed	Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.99e-10	6	89	4	32527940
Pubmed	Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.99e-10	6	89	4	20297805
Pubmed	Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.39e-09	7	89	4	8467709
Pubmed	Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.39e-09	7	89	4	8464825
Pubmed	Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.39e-09	7	89	4	27514509
Pubmed	Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.78e-09	8	89	4	17179145
Pubmed	Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.78e-09	8	89	4	20610558
Pubmed	Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.78e-09	8	89	4	18052087
Pubmed	A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.00e-09	9	89	4	22511988
Pubmed	Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.31e-09	10	89	4	23642732
Pubmed	UDP-glucuronosyltransferases.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.31e-09	10	89	4	11465080
Pubmed	A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.31e-09	10	89	4	23371916
Pubmed	A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.31e-09	10	89	4	22558097
Pubmed	Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4α Is Mediated by a Novel Composite Regulatory Element.	UGT1A10 UGT1A8 UGT1A9	1.62e-08	3	89	3	29519853
Pubmed	Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.	UGT1A10 UGT1A8 UGT1A9	1.62e-08	3	89	3	12847094
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.95e-08	12	89	4	20308471
Pubmed	Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.95e-08	12	89	4	19419973
Pubmed	Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.95e-08	12	89	4	11434514
Pubmed	UGT1A1 is a major locus influencing bilirubin levels in African Americans.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.81e-08	13	89	4	22085899
Pubmed	Genome-wide analysis of hepatic lipid content in extreme obesity.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.81e-08	13	89	4	25246029
Pubmed	Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.93e-08	14	89	4	21646302
Pubmed	Human UDP-glucuronosyltransferases: metabolism, expression, and disease.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.93e-08	14	89	4	10836148
Pubmed	Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.93e-08	14	89	4	14672974
Pubmed	The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.93e-08	14	89	4	9295054
Pubmed	Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A16 and 28.	UGT1A10 UGT1A7 UGT1A9	6.47e-08	4	89	3	17558305
Pubmed	Genome-wide association meta-analysis for total serum bilirubin levels.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.12e-08	16	89	4	19414484
Pubmed	Genome-wide association of serum bilirubin levels in Korean population.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.29e-08	17	89	4	20639394
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.19e-07	18	89	4	20056724
Pubmed	A genome-wide assessment of variability in human serum metabolism.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.51e-07	19	89	4	23281178
Pubmed	Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.	UGT1A8 UGT1A7 UGT1A9	1.61e-07	5	89	3	20565459
Pubmed	Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.	UGT1A10 UGT1A8 UGT1A9	1.61e-07	5	89	3	15057901
Pubmed	ATR/Chk1 signaling induces autophagy through sumoylated RhoB-mediated lysosomal translocation of TSC2 after DNA damage.	ATR TSC2 PIAS1	3.22e-07	6	89	3	30297842
Pubmed	Genetic determinants influencing human serum metabolome among African Americans.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.09e-07	24	89	4	24625756
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	CLCN6 UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.74e-07	66	89	5	19898482
Pubmed	Family-based genome-wide association scan of attention-deficit/hyperactivity disorder.	UGT1A10 UGT1A8 UGT1A9	1.35e-06	9	89	3	20732626
Pubmed	Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.	UGT1A8 UGT1A7 UGT1A9	2.63e-06	11	89	3	18695635
Pubmed	Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.	ATG2B GSKIP	6.48e-06	2	89	2	26280900
Pubmed	Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10.	UGT1A10 UGT1A9	6.48e-06	2	89	2	25547628
Pubmed	Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains.	ITGA10 ITGA1	6.48e-06	2	89	2	11572855
Pubmed	Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin.	EPHB2 KALRN	6.48e-06	2	89	2	12546821
Pubmed	Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues.	UGT1A10 UGT1A8	6.48e-06	2	89	2	11901093
Pubmed	ATG2B/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies.	ATG2B GSKIP	6.48e-06	2	89	2	33554699
Pubmed	Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.	UGT1A7 UGT1A9	6.48e-06	2	89	2	11677206
Pubmed	Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.	UGT1A10 UGT1A9	6.48e-06	2	89	2	22031623
Pubmed	Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.	UGT1A10 UGT1A8	6.48e-06	2	89	2	10497143
Pubmed	Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.	UGT1A8 UGT1A9	6.48e-06	2	89	2	18568343
Pubmed	Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes.	UGT1A10 UGT1A8	6.48e-06	2	89	2	17603215
Pubmed	UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.	UGT1A7 UGT1A9	6.48e-06	2	89	2	15709193
Pubmed	Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.	UGT1A7 UGT1A9	6.48e-06	2	89	2	12944498
Pubmed	New insights into ATR inhibition in muscle invasive bladder cancer: The role of apolipoprotein B mRNA editing catalytic subunit 3B.	ATR APOBEC3B	6.48e-06	2	89	2	38827321
Pubmed	Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon.	UGT1A10 UGT1A8	6.48e-06	2	89	2	9647757
Pubmed	Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.	UGT1A7 UGT1A9	6.48e-06	2	89	2	17529886
Pubmed	Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.	ATG2B GSKIP	6.48e-06	2	89	2	34172895
Pubmed	How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?	UGT1A10 UGT1A9	6.48e-06	2	89	2	20089735
Pubmed	Human metabolic individuality in biomedical and pharmaceutical research.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.43e-05	57	89	4	21886157
Pubmed	TSC2 modulates cell adhesion and migration via integrin-α1β1.	TSC2 ITGA1	1.94e-05	3	89	2	22923640
Pubmed	Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.	UGT1A7 UGT1A9	1.94e-05	3	89	2	19364970
Pubmed	Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.	UGT1A7 UGT1A9	1.94e-05	3	89	2	16636344
Pubmed	Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.	UGT1A10 UGT1A9	1.94e-05	3	89	2	20007669
Pubmed	Genetic polymorphisms of UGT1A8, UGT1A9 and HNF-1α and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid.	UGT1A8 UGT1A9	1.94e-05	3	89	2	23721685
Pubmed	Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites.	UGT1A10 UGT1A8	1.94e-05	3	89	2	19244109
Pubmed	Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9.	UGT1A8 UGT1A9	1.94e-05	3	89	2	26247833
Pubmed	The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.	UGT1A8 UGT1A9	1.94e-05	3	89	2	17339869
Pubmed	Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations.	UGT1A7 UGT1A9	1.94e-05	3	89	2	24453052
Pubmed	UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.	UGT1A8 UGT1A9	1.94e-05	3	89	2	19225446
Pubmed	[Influence of genetic polymorphisms in UGT1A1, UGT1A7 and UGT1A9 on the pharmacokynetics of irinotecan, SN-38 and SN-38G].	UGT1A7 UGT1A9	1.94e-05	3	89	2	23789755
Pubmed	Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer.	UGT1A7 UGT1A9	1.94e-05	3	89	2	17406868
Pubmed	Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions.	UGT1A8 UGT1A7	1.94e-05	3	89	2	19996319
Pubmed	Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.	UGT1A8 UGT1A9	1.94e-05	3	89	2	16397224
Pubmed	Loss of Atg2b and Gskip Impairs the Maintenance of the Hematopoietic Stem Cell Pool Size.	ATG2B GSKIP	1.94e-05	3	89	2	34748402
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	C2CD3 TULP4 KALRN RRP12 UBE3B UBR4 INTS1 TBC1D25 TSC2 RALGAPA2 HDAC7 GAREM1	2.49e-05	1105	89	12	35748872
Pubmed	Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients.	UGT1A8 UGT1A9	3.87e-05	4	89	2	18946804
Pubmed	Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients.	UGT1A8 UGT1A9	3.87e-05	4	89	2	20147615
Pubmed	UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy.	UGT1A7 UGT1A9	3.87e-05	4	89	2	20628391
Pubmed	Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.	UGT1A10 UGT1A7	3.87e-05	4	89	2	9271343
Pubmed	Genetic polymorphisms of UGT1A8, UGT1A9, UGT2B7 and ABCC2 in Chinese renal transplant recipients and a comparison with other ethnic populations.	UGT1A8 UGT1A9	3.87e-05	4	89	2	23700788
Pubmed	Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1.	UGT1A10 UGT1A9	3.87e-05	4	89	2	2108603
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	EPHB2 ZEB1 ZNF608 RRP12 INTS1 ELOVL1 PSMD1 FASTKD2 URB2 NCSTN PIAS1 APOBEC3B	5.66e-05	1203	89	12	29180619
Pubmed	UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.	GALNT18 GALNT13	6.44e-05	5	89	2	22186971
Pubmed	Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers.	UGT1A7 UGT1A9	6.44e-05	5	89	2	18597651
Pubmed	Effects of HIV-1 Nef on cellular gene expression profiles.	ZEB1 HLTF	6.44e-05	5	89	2	11810028
Pubmed	The major chemical-detoxifying system of UDP-glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C.	UGT1A10 UGT1A7	6.44e-05	5	89	2	18556656
Pubmed	Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients.	UGT1A7 UGT1A9	6.44e-05	5	89	2	17072959
Pubmed	Citrullination of collagen II affects integrin-mediated cell adhesion in a receptor-specific manner.	ITGA10 ITGA1	6.44e-05	5	89	2	24823363
Pubmed	Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.	UGT1A7 UGT1A9	9.65e-05	6	89	2	19204906
Pubmed	Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation.	NR2E1 HDAC7	9.65e-05	6	89	2	17873065
Pubmed	APOBEC deaminases-mutases with defensive roles for immunity.	APOBEC3B APOBEC4	1.35e-04	7	89	2	19911124
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	YEATS2 ZNF608 RALGAPA2 CEMIP	1.46e-04	103	89	4	10574462
Pubmed	Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism.	UGT1A8 UGT1A9	1.79e-04	8	89	2	12695355
Pubmed	Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk.	UGT1A8 UGT1A7	1.79e-04	8	89	2	15319294
Pubmed	A mouse knockout library for secreted and transmembrane proteins.	TMEM52 MYADM OLFML1 PGAP1 INTS1 ENPP5 ADGRA3	1.83e-04	460	89	7	20562862
Pubmed	Discovery and refinement of loci associated with lipid levels.	UGT1A10 UGT1A8 UGT1A7 OR4C46 UGT1A9	2.15e-04	211	89	5	24097068
Pubmed	BRCA1 promotes the ubiquitination of PCNA and recruitment of translesion polymerases in response to replication blockade.	ATR HLTF	2.30e-04	9	89	2	23901102
Pubmed	A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.	UGT1A8 UGT1A9	2.30e-04	9	89	2	1339448
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	EPHB2 PCYOX1L MYADM COL12A1 ATR PGAP1 RRP12 TSC2 ITGA1 NCSTN ADGRA3	2.47e-04	1201	89	11	35696571
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	COL12A1 ATR UGT1A8 PERP TSC2 CARD8	2.91e-04	351	89	6	20453000
Pubmed	An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.	A2M NCSTN	3.51e-04	11	89	2	19105203
Pubmed	Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.	UGT1A7 UGT1A9	4.20e-04	12	89	2	19349540
Pubmed	Rheb binds and regulates the mTOR kinase.	ATR TSC2	4.20e-04	12	89	2	15854902
Pubmed	Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.	ATR UBE3B UBR4	4.51e-04	58	89	3	31067491
Cytoband	2q37	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.99e-07	31	89	4	2q37
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	UGT1A10 UGT1A8 UGT1A7 UGT1A9 PSMD1	8.20e-05	226	89	5	chr2q37
GeneFamily	UDP glucuronosyltransferases	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.19e-06	32	62	4	363
GeneFamily	Fibronectin type III domain containing	EPHB2 COL12A1 KALRN ROS1 USH2A	2.20e-04	160	62	5	555
GeneFamily	Apolipoprotein B mRNA editing enzyme catalytic subunits	APOBEC3B APOBEC4	7.47e-04	12	62	2	406
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA10 ITGA1	1.71e-03	18	62	2	1160
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT18 GALNT13	2.11e-03	20	62	2	433
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M COL12A1 KALRN ABCA13 ROS1 USH2A GALNT13	8.86e-08	184	89	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M COL12A1 KALRN ABCA13 ROS1 USH2A GALNT13	8.86e-08	184	89	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M COL12A1 KALRN ABCA13 ROS1 USH2A GALNT13	8.86e-08	184	89	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M GJA4 ZEB1 ITGA10 ITGA1 HDAC7	1.51e-06	177	89	6	fdf2af00fc971f0cd3915e1416e4a256458d6ea8
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M GJA4 ZEB1 ITGA10 ITGA1 HDAC7	1.51e-06	177	89	6	12f8627124acbf436e75681ff1ce429ff5e3f256
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	ZEB1 KALRN ITGA1 RALGAPA2 GALNT18 SLC5A4	1.72e-06	181	89	6	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	ZEB1 KALRN ITGA10 LINGO2 ITGA1 GALNT18	1.77e-06	182	89	6	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	COVID-19-kidney-vSMC/Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	AKAP6 A2M GJA4 COL12A1 ZEB1 ITGA1	2.35e-06	191	89	6	fad8eaa536001b911d05ae2b12150c2398cc6f88
ToppCell	Control-Endothelial-VE_Capillary_B\|Control / Disease state, Lineage and Cell class	ZEB1 ZNF608 ITGA10 ITGA1 RALGAPA2 GALNT18	2.35e-06	191	89	6	322237793a1278bafb14e63cab688b353e352dcc
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZEB1 KALRN ITGA10 ITGA1 RALGAPA2 GALNT18	2.49e-06	193	89	6	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 KALRN ITGA10 ITGA1 RALGAPA2 GALNT18	2.72e-06	196	89	6	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZEB1 KALRN ITGA10 ITGA1 RALGAPA2 GALNT18	2.72e-06	196	89	6	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 ZNF608 ITGA1 RALGAPA2 GALNT18 SLC5A4	2.72e-06	196	89	6	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M COL12A1 ITGA10 ITGA1 IGLON5 CEMIP	2.81e-06	197	89	6	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT2 ABCA13 PGAP1 PERP GALNT18 CEMIP	2.89e-06	198	89	6	5374b0e98d669f36a0571d3c006c7bd5e3c8e87f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT2 ABCA13 PGAP1 PERP GALNT18 CEMIP	2.97e-06	199	89	6	94a7867e800df352731796de8c24cba133c29622
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZEB1 KALRN ITGA10 ITGA1 GALNT18 SLC5A4	2.97e-06	199	89	6	dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL12A1 ZEB1 ZNF608 RALGAPA2 HDAC7 GALNT18	3.06e-06	200	89	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GJA4 COL12A1 ZEB1 ZNF608 HDAC7 GALNT18	3.06e-06	200	89	6	f15fffefe372005c33e31845982e2d2714ac26af
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	GJA4 COL12A1 ZEB1 ZNF608 HDAC7 GALNT18	3.06e-06	200	89	6	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF608 PCDHB7 SAXO2 TUBD1 IGLON5	8.22e-06	137	89	5	e9b88ad86b75454a8292a94879c5b665adc42744
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DNAH3 PTPRN2 TMEM132D NDST4 USH2A	1.69e-05	159	89	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PCYOX1L ZEB1 ASAH2 URB2 ADGRA3	1.96e-05	164	89	5	583dda853cee9491dbdcb228c23d8deadc20eb08
ToppCell	Endothelial-endothelial_cell_of_bronchial_vessel\|World / Lineage, Cell type, age group and donor	A2M KALRN RALGAPA2 GALNT18 SLC5A4	2.02e-05	165	89	5	84e553d699ac56df89a77248f7308b9133e1b683
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL12A1 PCDHB14 PERP ITGA10 ITGA1	2.27e-05	169	89	5	1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL12A1 PCDHB14 PERP ITGA10 ITGA1	2.27e-05	169	89	5	58098f8801ca941aeddafb47e88ab0df8b9edb57
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	ZEB1 KALRN ITGA10 ITGA1 GALNT18	2.40e-05	171	89	5	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 PCDHB7 ITGA1 SLC5A4	2.47e-05	172	89	5	1ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 PCDHB7 ITGA1 SLC5A4	2.47e-05	172	89	5	ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 KALRN ITGA1 GALNT18 SLC5A4	3.07e-05	180	89	5	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	ZEB1 KALRN ITGA10 ITGA1 GALNT18	3.07e-05	180	89	5	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	368C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EPHB2 RRP12 UBE3B URB2 ITGA1	3.07e-05	180	89	5	eb5a57604c7f2ad256c300085dbf5069d0ae1ad0
ToppCell	368C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EPHB2 RRP12 UBE3B URB2 ITGA1	3.07e-05	180	89	5	ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 OLFML1 LIPJ ITGA1	3.23e-05	182	89	5	b7d532feb73167e05475855061b35a209583f44c
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCYOX1L ZNF608 SLC25A33 NDST4 GALNT13	3.23e-05	182	89	5	eb4be1c02b8b033d025e57b8b4cdbfaec4698054
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL12A1 ZEB1 KALRN PGAP1 ADGRA3	3.23e-05	182	89	5	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 OLFML1 LIPJ ITGA1	3.23e-05	182	89	5	af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M GJA4 COL12A1 ZEB1 ITGA1	3.49e-05	185	89	5	7092436b4db90289516ed130ade596e3021cffaf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M GJA4 COL12A1 ZEB1 ITGA1	3.49e-05	185	89	5	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M GJA4 COL12A1 ZEB1 ITGA1	3.49e-05	185	89	5	a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ZEB1 KALRN RALGAPA2 GALNT18 SLC5A4	3.49e-05	185	89	5	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BNC1 FAT2 ABCA13 UGT1A8 PERP	3.49e-05	185	89	5	e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M MYADM COL12A1 OLFML1 ITGA1	3.49e-05	185	89	5	e1fbec55b71f604189eb2431768fadbaa0453a83
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M MYADM COL12A1 OLFML1 ITGA1	3.49e-05	185	89	5	9d933cd5ebc8368fd37aa83113d2dfa6938ff72d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M GJA4 COL12A1 ZEB1 ITGA1	3.49e-05	185	89	5	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	Control-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	ZEB1 KALRN ITGA10 ITGA1 GALNT18	3.49e-05	185	89	5	a28187c2fd23564314b35759479ff2ca21f61485
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	AKAP6 A2M COL12A1 KALRN ITGA1	3.68e-05	187	89	5	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ZEB1 KALRN ITGA10 RALGAPA2 GALNT18	3.68e-05	187	89	5	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	ZEB1 ZNF608 ITGA10 ITGA1 GALNT18	3.68e-05	187	89	5	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	Control-Endothelial-VE_Capillary_A\|Control / Disease state, Lineage and Cell class	ZEB1 KALRN ITGA10 ITGA1 GALNT18	3.68e-05	187	89	5	54d7588172ac145ff5045ad9771636729ca3f0ca
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M COL12A1 PCDHB14 LINGO2 ITGA1	3.77e-05	188	89	5	116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	ZEB1 KALRN ITGA10 ITGA1 GALNT18	3.77e-05	188	89	5	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122\|Adult / Lineage, Cell type, age group and donor	ZEB1 ITGA10 ITGA1 GALNT18 SLC5A4	3.77e-05	188	89	5	02a62888e9db29d20133eeca1686d302545a39c9
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZEB1 KALRN ITGA10 ITGA1 GALNT18	3.87e-05	189	89	5	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	IPF-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	ZEB1 KALRN ITGA10 ITGA1 GALNT18	3.87e-05	189	89	5	ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	ZEB1 ITGA1 RALGAPA2 GALNT18 SLC5A4	3.97e-05	190	89	5	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 KALRN RALGAPA2 GALNT18 SLC5A4	3.97e-05	190	89	5	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	IPF-Endothelial-VE_Capillary_A\|IPF / Disease state, Lineage and Cell class	ZEB1 KALRN ITGA10 ITGA1 GALNT18	3.97e-05	190	89	5	b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZEB1 KALRN ITGA10 ITGA1 GALNT18	3.97e-05	190	89	5	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZEB1 KALRN ITGA10 ITGA1 GALNT18	3.97e-05	190	89	5	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 ZEB1 KALRN ITGA1	3.97e-05	190	89	5	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ZEB1 KALRN RALGAPA2 GALNT18 SLC5A4	3.97e-05	190	89	5	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF608 NR2E1 NDST4 PKP2 GALNT13	4.07e-05	191	89	5	764c3a8829ae1253a0790744138266e81fc075ec
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 TMEM132D ABCA13 GALNT18 ADGRA3	4.07e-05	191	89	5	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	Control-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	ZEB1 ITGA10 ITGA1 RALGAPA2 GALNT18	4.07e-05	191	89	5	c672c8e28d06d555335976b3f8bd2ea6d3b34aae
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZEB1 KALRN ITGA10 ITGA1 GALNT18	4.07e-05	191	89	5	f229abf69a1217194f74b0502486907e07dba989
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	EPHB2 COL12A1 ZEB1 OLFML1 LINGO2	4.07e-05	191	89	5	156b467187331ac6ca390d6ca861d9670bb7b956
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 KALRN ITGA1 GALNT18 SLC5A4	4.07e-05	191	89	5	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GJA4 COL12A1 ZEB1 KALRN ITGA1	4.07e-05	191	89	5	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	A2M KALRN ITGA1 RALGAPA2 GALNT18	4.07e-05	191	89	5	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GJA4 COL12A1 ZEB1 KALRN ITGA1	4.07e-05	191	89	5	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	ZEB1 KALRN ITGA10 ITGA1 GALNT18	4.17e-05	192	89	5	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	A2M KALRN ITGA1 RALGAPA2 GALNT18	4.17e-05	192	89	5	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADORA2A NR2E1 URB2 E2F8 ADGRA3	4.17e-05	192	89	5	d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC1 FAT2 ABCA13 UGT1A7 PERP	4.27e-05	193	89	5	7c34abdcb8839b9fb25457a79af6c5e7b9714b21
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_10\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADORA2A GJA4 ZEB1 ZNF608 NPFFR1	4.27e-05	193	89	5	7426a30ed01e5c8376b3e0ebe0f1057cfee88340
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ZEB1 KALRN ITGA1 RALGAPA2 GALNT18	4.27e-05	193	89	5	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_10\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADORA2A GJA4 ZEB1 ZNF608 NPFFR1	4.27e-05	193	89	5	a2194012dfa0174c6160900625c44e0fd04c50e7
ToppCell	IPF-Endothelial-VE_Venous\|IPF / Disease state, Lineage and Cell class	ZEB1 KALRN ITGA10 RALGAPA2 GALNT18	4.27e-05	193	89	5	29a655fa80feaabe846c90a28363b037e22d24ae
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|metastatic_Brain / Location, Cell class and cell subclass	A2M GJA4 ZEB1 OLFML1 ITGA1	4.38e-05	194	89	5	d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M ZEB1 ZNF608 ITGA1 GALNT18	4.38e-05	194	89	5	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	IPF-Endothelial-VE_Capillary_B\|IPF / Disease state, Lineage and Cell class	ZEB1 ITGA10 ITGA1 RALGAPA2 GALNT18	4.38e-05	194	89	5	169a304d5c13f08c39fad4116f093bc4a0765e9d
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZEB1 ZNF608 ITGA10 ITGA1 GALNT18	4.38e-05	194	89	5	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	IPF-Endothelial\|IPF / Disease state, Lineage and Cell class	ZEB1 KALRN ITGA10 RALGAPA2 GALNT18	4.38e-05	194	89	5	9591993aa2dcba3d09a0f1ea8b8f2439c26482d6
ToppCell	11.5-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	A2M GJA4 COL12A1 PERP ITGA1	4.38e-05	194	89	5	08701590496cf85ff790e54a81493c61177e76ff
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZEB1 ZNF608 ITGA10 ITGA1 GALNT18	4.38e-05	194	89	5	40842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCell	Control-Endothelial\|Control / Disease state, Lineage and Cell class	ZEB1 KALRN ITGA1 RALGAPA2 GALNT18	4.38e-05	194	89	5	485fe5538fabec457b9a51feb641f2a91cbf4e18
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ZEB1 KALRN ITGA1 GALNT18 SLC5A4	4.49e-05	195	89	5	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	A2M KALRN ITGA1 RALGAPA2 GALNT18	4.49e-05	195	89	5	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 ZEB1 KALRN ITGA1	4.49e-05	195	89	5	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	IPF-Endothelial-VE_Peribronchial\|IPF / Disease state, Lineage and Cell class	ZEB1 KALRN ITGA10 RALGAPA2 GALNT18	4.49e-05	195	89	5	2c3ad3cb79f11119ac69c413a938d21199145040
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 ZEB1 KALRN ITGA1	4.49e-05	195	89	5	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M GJA4 COL12A1 OLFML1 ITGA1	4.49e-05	195	89	5	9ab3c5b0fb12d406408122a535b717bfe184bbcf
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M GJA4 COL12A1 OLFML1 ITGA1	4.49e-05	195	89	5	21263d138c81f6a0219f2cd93126cfafd35732b2
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	A2M KALRN ITGA1 GALNT18 CARD8	4.49e-05	195	89	5	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GJA4 COL12A1 OLFML1 ITGA10 ITGA1	4.60e-05	196	89	5	40e6900a0d56088a40d37ec312f53207ea952602
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 ZEB1 KALRN ITGA1	4.60e-05	196	89	5	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GJA4 COL12A1 OLFML1 ITGA10 ITGA1	4.60e-05	196	89	5	7acd782a587b7d331517f60daa8b5c2177bedfc7
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MYADM PERP ITGA10 GALNT18 GALNT13	4.60e-05	196	89	5	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FAT2 UGT1A10 UGT1A7 PERP CEMIP	4.60e-05	196	89	5	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
Drug	AC1O5XMV	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	3.10e-10	11	86	5	CID006442661
Drug	tritanol	TMEM132D UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.59e-10	13	86	5	CID000006457
Drug	naringenin chalcone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.46e-10	5	86	4	ctd:C027329
Drug	anthrarobin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.46e-10	5	86	4	ctd:C032186
Drug	1,2,5,8-tetrahydroxy anthraquinone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.83e-09	6	86	4	ctd:C543211
Drug	alloin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.83e-09	6	86	4	ctd:C006457
Drug	2',5'-dihydroxychalcone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.83e-09	6	86	4	ctd:C107497
Drug	quercetin-3,4'-diglucoside	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	2.89e-09	16	86	5	CID005320835
Drug	3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	4.08e-09	17	86	5	CID000003573
Drug	ApApG	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	5.63e-09	18	86	5	CID003081975
Drug	2',4'-dihydroxychalcone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.58e-09	7	86	4	ctd:C059354
Drug	AC1L1OBF	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.01e-08	20	86	5	CID000032736
Drug	1,4-dihydroxyanthraquinone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.31e-08	8	86	4	ctd:C034890
Drug	AC1MRQNQ	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.36e-08	9	86	4	CID003522271
Drug	DHPASiU	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.36e-08	9	86	4	CID000197602
Drug	Chebi:32663	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.36e-08	9	86	4	CID005460873
Drug	3-iodophenol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.36e-08	9	86	4	CID000012272
Drug	AC1L4J7U	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.36e-08	9	86	4	CID000186631
Drug	2,6-dihydroxyanthraquinone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.92e-08	10	86	4	ctd:C034889
Drug	diflunisal	ZEB1 UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.17e-08	27	86	5	CID000003059
Drug	4-nitrophenyl)imidazole	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.14e-08	11	86	4	CID000123155
Drug	CARMINE	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	6.27e-08	28	86	5	CID000014749
Drug	7-hydroxy-4-trifluoromethylcoumarin	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	7.56e-08	29	86	5	CID005375667
Drug	dihydroartemisinin	TMEM132D UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.04e-08	30	86	5	CID000107770
Drug	N-OH-DABZ	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.18e-08	12	86	4	CID000051366
Drug	1-O-beta-D-glucopyranosyl-D-mannitol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.18e-08	12	86	4	CID000088735
Drug	4-hydroxyestrone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.18e-08	12	86	4	ctd:C026418
Drug	2,4,6-TCB	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.18e-08	12	86	4	CID000037247
Drug	7,7,7-triphenylheptanoic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.18e-08	12	86	4	CID000276709
Drug	nonanoyl-N-methylglucamide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.18e-08	12	86	4	CID000160090
Drug	PCB 156	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.07e-07	31	86	5	CID000038019
Drug	4'-HPPH	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.07e-07	31	86	5	CID000017732
Drug	NNAL	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.27e-07	32	86	5	CID000104856
Drug	2-hydroxyestrone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.32e-07	13	86	4	ctd:C024980
Drug	5-azido-UDP-glucuronic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.32e-07	13	86	4	CID003081279
Drug	cotinine-N-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.32e-07	13	86	4	CID000000411
Drug	alizarin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.32e-07	13	86	4	ctd:C010078
Drug	geniposide	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.49e-07	33	86	5	CID000107848
Drug	propranolol glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.84e-07	14	86	4	CID000119515
Drug	PCB-61	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.84e-07	14	86	4	CID000036401
Drug	estrone-3-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	2.03e-07	35	86	5	CID000115255
Drug	2-vanillin	UGT1A10 UGT1A8 UGT1A7	2.08e-07	4	86	3	ctd:C060843
Drug	hydratropic acid	UGT1A10 UGT1A8 UGT1A7	2.08e-07	4	86	3	ctd:C013025
Drug	diphenylacetic acid	UGT1A10 UGT1A8 UGT1A7	2.08e-07	4	86	3	ctd:C037760
Drug	bevirimat	TMEM132D UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.35e-07	36	86	5	CID000457928
Drug	2,2',3,5,5'-pentachlorobiphenyl	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.51e-07	15	86	4	CID000040469
Drug	coumarin-3-carboxylic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.51e-07	15	86	4	CID000010752
Drug	bergamottin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.51e-07	15	86	4	ctd:C068337
Drug	sulforaphane nitrile	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.51e-07	15	86	4	CID000543743
Drug	afloqualone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.51e-07	15	86	4	CID000002040
Drug	naphthyl sulphate	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.51e-07	15	86	4	CID000114775
Drug	4-methylumbelliferyl glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	3.11e-07	38	86	5	CID000091553
Drug	1'-hydroxyestragole	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.34e-07	16	86	4	CID000040003
Drug	bilirubin-phosphate	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.34e-07	16	86	4	CID005497144
Drug	1-phenylimidazole	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	3.56e-07	39	86	5	CID000081595
Drug	6-hydroxychrysene	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.35e-07	17	86	4	CID000037766
Drug	testosterone glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	4.60e-07	41	86	5	CID000108192
Drug	isovaleric acid	UGT1A10 UGT1A8 UGT1A7	5.17e-07	5	86	3	ctd:C008216
Drug	biphenylylacetic acid	UGT1A10 UGT1A8 UGT1A7	5.17e-07	5	86	3	ctd:C012776
Drug	L 654969	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	5.21e-07	42	86	5	CID000005218
Drug	ethyl-beta-D-6-glucosiduronic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.58e-07	18	86	4	CID000152226
Drug	Br 2	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.58e-07	18	86	4	CID003060900
Drug	SureCN12722713	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.58e-07	18	86	4	CID005488034
Drug	2,3,7-trichlorodibenzo-p-dioxin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.58e-07	18	86	4	CID000036614
Drug	C1 11-32	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.58e-07	18	86	4	CID000443077
Drug	C11131	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.58e-07	18	86	4	CID000443076
Drug	N-hydroxy-PhIP	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	5.88e-07	43	86	5	CID000104954
Drug	anthraflavic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	6.61e-07	44	86	5	CID000006776
Drug	almokalant	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.04e-07	19	86	4	CID003033962
Drug	9-OH-risperidone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.04e-07	19	86	4	CID000475100
Drug	5alpha-spirostan-3beta-ol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.04e-07	19	86	4	CID000091433
Drug	tectochrysin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.78e-07	20	86	4	CID005281954
Drug	4'-hydroxydiclofenac	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.78e-07	20	86	4	CID000116545
Drug	entacapone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.78e-07	20	86	4	ctd:C071192
Drug	pentoxyresorufin	ZEB1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	9.62e-07	87	86	6	CID000107683
Drug	UDP-N-acetylglucosamine	TMEM132D UGT1A10 UGT1A8 UGT1A7 ELOVL1 UGT1A9 GALNT18 GALNT13	1.02e-06	203	86	8	CID000001167
Drug	1-hydroxypyrene	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.03e-06	48	86	5	CID000021387
Drug	retigabine	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.03e-06	48	86	5	CID000121892
Drug	3-phenylpropionic acid	UGT1A10 UGT1A8 UGT1A7	1.03e-06	6	86	3	ctd:C035253
Drug	Indoprofen	UGT1A10 UGT1A8 UGT1A7	1.03e-06	6	86	3	ctd:D007216
Drug	estriol-16-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.08e-06	21	86	4	CID000122281
Drug	dulcin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.08e-06	21	86	4	CID000009013
Drug	Benzamidoxime hydrochloride	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.08e-06	21	86	4	CID000069186
Drug	campestrol	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.14e-06	49	86	5	CID000010134
Drug	scopoletin	UGT1A10 UGT1A8 UGT1A7 PERP UGT1A9	1.27e-06	50	86	5	CID005280460
Drug	amonafide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.32e-06	22	86	4	CID000050515
Drug	plumbagin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.32e-06	22	86	4	ctd:C014758
Drug	N-methylpiperazine	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.32e-06	22	86	4	CID000053167
Drug	Finrazole	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.40e-06	51	86	5	CID000178036
Drug	amidoxime	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-06	23	86	4	CID000465967
Drug	estradiol-3-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-06	23	86	4	CID000066651
Drug	phenanthridine	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-06	23	86	4	CID000009189
Drug	tangeretin	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC45A2	1.87e-06	54	86	5	CID000068077
Drug	AS-3201	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.90e-06	24	86	4	CID000153948
Drug	Invader	UGT1A10 UGT1A8 UGT1A7 UGT1A9 CEMIP	2.24e-06	56	86	5	CID006442259
Drug	5-MOP	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.26e-06	25	86	4	CID000002355
Drug	Hymecromone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.26e-06	25	86	4	ctd:D006923
Drug	AzMC	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.26e-06	25	86	4	CID000064986
Drug	N-acetylbenzidine	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.26e-06	25	86	4	CID000018787
Drug	5,6-benzoquinoline	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.26e-06	25	86	4	CID000006796
Disease	N-acetyl-4-chlorophenylalanine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.68e-10	5	88	4	EFO_0801060
Disease	5-hydroxyindole sulfate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.68e-10	5	88	4	EFO_0800085
Disease	nuclear receptor subfamily 1 group D member 2 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.68e-10	5	88	4	EFO_0801853
Disease	X-21339 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.57e-09	7	88	4	EFO_0800808
Disease	X-11793--oxidized bilirubin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0021260
Disease	Succinimide measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0022118
Disease	X-11530 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0801034
Disease	cholelithiasis, bilirubin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0004570, EFO_0004799
Disease	X-11522 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0800696
Disease	X-10458 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0800692
Disease	X-24849 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0800909
Disease	serum N-desmethylclozapine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0600043
Disease	plasma clozapine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0600038
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0802740
Disease	X-16946 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.12e-09	8	88	4	EFO_0800766
Disease	X-11442 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-09	9	88	4	EFO_0021236
Disease	X-11441 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-09	9	88	4	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-09	9	88	4	EFO_0004739
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-09	9	88	4	EFO_0801037
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-09	9	88	4	EFO_0802127
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-09	9	88	4	EFO_0801036
Disease	X-11880 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-09	9	88	4	EFO_0800698
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-09	9	88	4	EFO_0004570, GO_0009410
Disease	protein-tyrosine kinase 6 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-09	9	88	4	EFO_0020691
Disease	X-21448 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.53e-08	10	88	4	EFO_0800816
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.53e-08	10	88	4	EFO_0802185
Disease	X-23974 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.53e-08	10	88	4	EFO_0800867
Disease	bilirubin measurement, response to tenofovir	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.53e-08	10	88	4	EFO_0004570, EFO_0009279
Disease	xanthurenate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9 LINGO2	2.36e-08	29	88	5	EFO_0010551
Disease	X-21796 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.40e-08	11	88	4	EFO_0800825
Disease	pregnenetriol sulfate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.40e-08	11	88	4	EFO_0800586
Disease	plasma N-desmethylclozapine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.40e-08	11	88	4	EFO_0600039
Disease	insomnia, bilirubin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.40e-08	11	88	4	EFO_0004570, EFO_0004698
Disease	histidine betaine (hercynine) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.40e-08	11	88	4	EFO_0800972
Disease	aldosterone measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.40e-08	11	88	4	EFO_0010219
Disease	blood 4-oxo-retinoic acid measurement	UGT1A10 UGT1A8 UGT1A9	2.56e-08	3	88	3	EFO_0022216
Disease	indole-3-carboxylate measurement	UGT1A10 UGT1A8 UGT1A9	2.56e-08	3	88	3	EFO_0800043
Disease	biliverdin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.59e-08	12	88	4	EFO_0021033
Disease	p-cresol glucuronide measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.59e-08	12	88	4	EFO_0800079
Disease	retinol dehydrogenase 16 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.17e-08	13	88	4	EFO_0802007
Disease	pregnenetriol disulfate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.17e-08	13	88	4	EFO_0800587
Disease	X-21441 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.71e-07	17	88	4	EFO_0800814
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.71e-07	17	88	4	EFO_0004611, EFO_0007800
Disease	angiopoietin-related protein 1 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.19e-07	18	88	4	EFO_0801382
Disease	tissue factor measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.25e-07	21	88	4	EFO_0010623
Disease	3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement	UGT1A10 UGT1A8 UGT1A9	5.09e-07	6	88	3	EFO_0800566
Disease	neuroblastoma, cutaneous melanoma	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.43e-06	28	88	4	EFO_0000389, EFO_0000621
Disease	response to dolutegravir	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.91e-06	30	88	4	EFO_0600017
Disease	indoleacetate measurement	UGT1A10 UGT1A8 UGT1A9	3.03e-06	10	88	3	EFO_0021015
Disease	vitamin D deficiency	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.52e-06	37	88	4	EFO_0003762
Disease	thyroxine measurement	ADORA2A UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.08e-06	83	88	5	EFO_0005130
Disease	hormone measurement	TMEM132D UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.39e-06	84	88	5	EFO_0004730
Disease	X-24588 measurement	UGT1A10 UGT1A8 UGT1A9	7.17e-06	13	88	3	EFO_0800898
Disease	vitamin D measurement, COVID-19	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.41e-05	49	88	4	EFO_0004631, MONDO_0100096
Disease	gallstones	UGT1A10 UGT1A8 UGT1A7 RRP12 UGT1A9	1.84e-05	108	88	5	EFO_0004210
Disease	urate measurement, spine bone mineral density	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.77e-05	58	88	4	EFO_0004531, EFO_0007701
Disease	attention deficit hyperactivity disorder	AKAP6 PTPRN2 UGT1A10 UGT1A8 UGT1A9 ITGA1 GALNT13	9.31e-05	354	88	7	EFO_0003888
Disease	cholelithiasis	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.42e-04	88	88	4	EFO_0004799
Disease	lifestyle measurement, diastolic blood pressure	GALNT18 GAREM1	1.83e-04	7	88	2	EFO_0006336, EFO_0010724
Disease	urinary 6‑hydroxymelatonin sulfate to creatinine ratio	GALNT18 GALNT13	3.90e-04	10	88	2	EFO_0021488
Disease	urate measurement, bone density	AKAP6 PTPRN2 UGT1A10 UGT1A8 UGT1A7 UGT1A9 USH2A GALNT18	5.28e-04	619	88	8	EFO_0003923, EFO_0004531
Disease	dodecanedioate measurement	UGT1A10 UGT1A8	5.69e-04	12	88	2	EFO_0021054
Disease	Myeloproliferative disease	ATG2B GSKIP	5.69e-04	12	88	2	C0027022
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.97e-04	147	88	4	DOID:9352 (biomarker_via_orthology)
Disease	thyroxine measurement, triiodothyronine measurement	EPHB2 GALNT13	1.16e-03	17	88	2	EFO_0005130, EFO_0008392
Disease	Myeloid Leukemia	ATG2B GSKIP	1.30e-03	18	88	2	C0023470
Disease	Leukemia, Monocytic, Chronic	ATG2B GSKIP	1.30e-03	18	88	2	C0023466
Disease	complement factor H-related protein 3 measurement	AKAP6 COL12A1 KALRN USH2A	1.67e-03	169	88	4	EFO_0600056
Disease	Etat Marbre	ADORA2A TSEN54	2.14e-03	23	88	2	C0266487
Disease	visuospatial function measurement	LINGO2 LRRD1	2.73e-03	26	88	2	EFO_0803533
Disease	cholesteryl ester 14:0 measurement	PTPRN2 CARD8	2.94e-03	27	88	2	EFO_0010340

Protein segments in the cluster

Peptide	Gene	Start	Entry
TLLSHVALYQGVYSQ	URB2	1146	Q14146
HPNVTLTISAARLYY	APOBEC3B	111	Q9UH17
LSHTNSVVNPFIYAY	ADORA2A	276	P29274
PGITLSIYFSQLYHT	APOBEC4	146	Q8WW27
LYTQAASLLHPVVYT	ADGRA3	751	Q8IWK6
VYPITQVHSASLESY	BNC1	831	Q01954
PPHVSYTIRTNVLYS	ABCA13	3481	Q86UQ4
RSTHYQQYQPVVTLQ	CEMIP	1036	Q8WUJ3
SNSHYVLELTLPNIY	ATG2B	931	Q96BY7
HNVYINGITYTPVSS	A2M	646	P01023
LQHYIAVSSPTNTTY	NCSTN	551	Q92542
SILTYVAHTSALTYP	PTPRN2	191	Q92932
YTTVLFSHIYLAPLA	NPFFR1	216	Q9GZQ6
QLSYTALFPQLQVHY	KIAA0100	1321	Q14667
LVSLHAYNNQISYLP	LRRD1	676	A4D1F6
TTSQYHIISPLQNGY	HSFY1	321	Q96LI6
QTISAYLIYLSQHTP	INTS1	1061	Q8N201
DLNLVHYNQTTSPLY	LIPJ	281	Q5W064
TIYGPHTLSAYIQLF	ASAH2	596	Q9NR71
AYSTLQLVTNPYQAT	POLD2	321	P49005
PRIYISDLLAHTQYT	EPHB2	391	P29323
PTVVSLVHGYLNSSY	PCYOX1L	331	Q8NBM8
SLSTYQINHYTPQFE	FAT2	701	Q9NYQ8
YSSVNTPNLITHSLY	OR4C46	71	A6NHA9
LVIYPVKYTQTFTLH	PERP	126	Q96FX8
TFTLHANPAVTYIYN	PERP	136	Q96FX8
NVFITKTYPNHYTLV	ENPP5	66	Q9UJA9
PTLSYYSSGLHNISV	GAREM1	566	Q9H706
ITLHDTYESPTSYIL	KALRN	2741	O60229
ASIIYPTTYVQFLSH	MYADM	116	Q96S97
HLVYLTHLNLSYNPI	LINGO2	271	Q7L985
TIFQYNHSTYQPVLL	NDST4	221	Q9H3R1
SAYNTRTIVHYSPNL	ITGA1	851	P56199
TYTQQSHYILTLADL	RALGAPA2	1311	Q2PPJ7
VGRALVYQHSPSTYI	OLFML1	256	Q6UWY5
YSVINRSPHYLLSEV	GALNT13	136	Q8IUC8
LIPTIVSYTYIISTN	OR9A1P	211	Q8NGU1
SLQNYTISPNSHFYI	PCDHB14	166	Q9Y5E9
SLSNYTISPNAYFHI	PCDHB7	166	Q9Y5E2
TPYHETVYSLLDTLS	GSKIP	101	Q9P0R6
ITEHTNYLAPYQFLT	ATR	2126	Q13535
YVYPHTRIQSLVSIL	CLCN6	611	P51797
TRHQPYTTQVYLIVH	IGLON5	116	A6NGN9
VQYYFPVQHSQSSVL	C2CD3	1031	Q4AC94
YAIYLQPTQAHQSVT	E2F8	521	A0AVK6
LHNLNPSTTYDVNVY	COL12A1	2171	Q99715
HNYVTPTSYLELILT	DNAH3	2646	Q8TD57
HYVVPTLASQSRYDL	FCGBP	251	Q9Y6R7
VYYTSSQQIHVGILS	GALNT18	506	Q6P9A2
LSIPITSNTLIYYHP	CARD8	311	Q9Y2G2
LIQFVLVSLHISQYY	ELOVL1	206	Q9BW60
TSAYIQYEPHLLFSS	ITGA10	931	O75578
STALYPSIYLNTQQS	SPAM1	256	P38567
STPTLVYLGHVIYLS	GJA4	86	P35212
IVLTTYNILTHDYGT	HLTF	526	Q14527
VLFLYLPSNSSLTHY	CCDC168	4266	Q8NDH2
QTFYQDPSVLYISLH	HDAC7	716	Q8WUI4
STLYTVPFNLITEYH	SLC45A2	436	Q9UMX9
AQLTLNSYIHTRYPT	NR2E1	321	Q9Y466
NYTVLTSVLNPFIYS	OR1L3	276	Q8NH93
QGPSSHYYTTLVTLI	NINJ2	56	Q9NZG7
YVTLLQIHSIYSQLI	RNF139	141	Q8WU17
RQHTVTGLQPYTNYS	USH2A	3641	O75445
LLVSHLQPYSQYNFS	USH2A	4406	O75445
YQLLLTDHTVTFLQY	TSEN54	141	Q7Z6J9
DLLTTYAVTHPQVSY	TBC1D25	316	Q3MII6
SLLPTYLPVTYHINN	TMEM132D	41	Q14C87
ILSILHTYSSLNHVY	FASTKD2	456	Q9NYY8
VVSLLSESYNPHVRY	PSMD1	636	Q99460
QLIHYTESISSYLGP	SLC5A4	451	Q9NY91
QDYPSLSHLVVYVPS	PGAP1	431	Q75T13
TSYINTSLIQDYRHP	PIAS1	516	O75925
YPVTLQVYHGLLSFT	RRP12	231	Q5JTH9
LRTVYYPQVHLGTIS	SLC25A33	46	Q9BSK2
NITAPSSPHIYQVYS	AKAP6	1276	Q13023
IVQNYNSILTLSHLY	TUBD1	181	Q9UJT1
SVHYQTPLGYERITT	TULP4	876	Q9NRJ4
QTPVTAYDLYSHTSI	UGT1A10	236	Q9HAW8
VHSTVTSYSSVQYPL	TMEM52	111	Q8NDY8
YYSIISHTLHRILQP	ROS1	1301	P08922
QTPVTEYDLYSHTSI	UGT1A9	236	O60656
LLNSTSHLDYVPYQA	SAXO2	246	Q658L1
ILIPQVAYTYSTTVS	ZEB1	836	P37275
PSPTSYIHENYLQLF	UBE3B	761	Q7Z3V4
VITQRHPALAQSLYY	ZNF608	1066	Q9ULD9
HYSLSTNSPPLIQYV	TRIM64C	386	A6NLI5
PYIIHTVLYVLNTTR	UBR4	4991	Q5T4S7
NLHRTSSVPEYVYNL	PKP2	76	Q99959
QTPVTAYDLYSHTSI	UGT1A7	236	Q9HAW7
HLTYTSYILKQTPQG	YEATS2	846	Q9ULM3
VVPVLTALISYHNYL	TSC2	766	P49815
QTPVTAYDLYSHTSI	UGT1A8	236	Q9HAW9